Robert B. Good - Concepedia

Concepedia

Author

Robert B. Good

GlaxoSmithKline (United Kingdom)ORCID

Also Known As

Good, R, R Good, Robert B. Good, Robert Barnett, Robert Good

20

Publications

1.2K

Citations

10

H-Index

27

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)University College London Novartis (United Kingdom)The Royal Free Hospital CRUK Lung Cancer Centre of Excellence

RB

About

Robert B. Good is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, magnetic resonance imaging, and radiologic imaging.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	119
2	Engineering	1	1	25
3	Health Sciences	1	1	94
4	Public Health	1	1	347
5	Biomedical Engineering	1	1	347

Robert B. Good

×

10

Publications

1.2K

Citations

10

H-Index

	Year	Citations
Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension Robert B. Good, A Gilbane, Sarah L. Trinder, American Journal Of Pathology Pulmonary Arterial HypertensionPulmonary CirculationMesenchymal Transition ContributesPhysiologyEndothelial Dysfunction	2015	347
A Novel Murine Model of Severe Pulmonary Arterial Hypertension Loredana Ciuclan, Olivier Bonneau, Martin Hussey, American Journal of Respiratory and Critical Care Medicine	2011	246
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis Hannah V. Woodcock, Jessica Eley, Delphine Guillotin, Nature Communications	2018	219
MR imaging of musculoskeletal tumors and tumor mimickers with intravenous gadolinium: experience with 242 patients Dave A. May, Robert B. Good, David K. Smith, Skeletal Radiology Imaging AnatomyMedical ImagingMusculoskeletal ImagingPet-mriMr Imaging	1997	94
Imatinib Attenuates Hypoxia-induced Pulmonary Arterial Hypertension Pathology via Reduction in 5-Hydroxytryptamine through Inhibition of Tryptophan Hydroxylase 1 Expression Loredana Ciuclan, Martin Hussey, Victoria J. Burton, American Journal of Respiratory and Critical Care Medicine	2013	71
Impaired Bone Morphogenetic Protein Receptor II Signaling in a Transforming Growth Factor-β–Dependent Mouse Model of Pulmonary Hypertension and in Systemic Sclerosis A Gilbane, Emma Derrett‐Smith, Sarah L. Trinder, American Journal of Respiratory and Critical Care Medicine	2015	47
Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis Sarah Rank Rønnow, Rand Qais Dabbagh, Federica Genovese, Respiratory Research	2020	42
A high content, phenotypic ‘scar-in-a-jar’ assay for rapid quantification of collagen fibrillogenesis using disease-derived pulmonary fibroblasts Robert B. Good, Jessica Eley, Elaine Gower, BMC Biomedical Engineering	2019	34
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells Krishna K. Kolluri, Constantine Alifrangis, Neelam Kumar, eLife	2018	28
Single-Step, High-Efficiency CRISPR-Cas9 Genome Editing in Primary Human Disease-Derived Fibroblasts Matteo Martufi, Robert B. Good, Radu Rapiteanu, The CRISPR Journal Gene TherapiesOff-target EffectEngineeringGenome SurgeryNovel Therapy	2019	25

Page 1